01:46:31

IEC Symposium on Infections and Immunization in Patients with Atopic Dermatitis | RADLA 2024

02:42

Presenter Panel Discussion and Audience Q&A | All Presenters| EAACI 2024

04:57

The real world data | Marjolein de Bruin Weller MD PhD | EAACI 2024

11:46

The experience from clinical trials | Alan Irvine MD DSc | EAACI 2024

12:35

Mechanisms and consequences of Jak STAT signaling in the immune system Ioana Agache MD PhD

06:29

Welcome from the IEC & Program Overview Alan Irvine, MD DSc EAACI 2024

01:56:02

IEC Symposium on What's New in Pathogenesis & Mechanisms? Drivers of Disease Part 2 10-12 PM Central

01:44:45

IEC Symposium on What's New in Pathogenesis & Mechanisms? Drivers of Disease Part 1 8-10 AM Central

23:11

Cardiovascular Comorbidities

21:45

Autoimmune Comorbidities

25:06

Psychiatric Comorbidities

22:33

Economics and Healthcare in Atopic Dermatitis

25:30

Atopic Dermatitis Topical Study Design

24:57

PDE-4 Inhibitors

18:30

Topical therapies: Tapinarof and beyond

19:07

Topical JAK Inhibitors in AD

25:44

Mechanisms for Prevention of Atopic Dermatitis using Topical Products

01:14:27

IEC Virtual Learning Series - Management of AD Patients on Systemic Treatments During COVID 19

06:56

New Treatments for Atopic Dermatitis for Infants and Children - Welcome, Dr. Emma Guttman

18:27

New Treatments for Atopic Dermatitis for Infants and Children - Systemic Therapies, Dr. Amy Paller

17:50

New Treatments for AD for Infants and Children - Topical Therapies, Dr. Melinda Gooderham

13:31

New Treatments for AD for Infants and Children - Mechanisms for Prevention of AD, Dr. Michael Cork

06:39

New Treatments for AD for Infants and Children - Overview of Pediatric AD, Dr. Antonio Torrelo

23:29

New Treatments for Atopic Dermatitis for Infants and Children - Q&A Session

09:56

Monoclonal antibodies targeting epithelial-derived protein (e.g. IL-17C, IL-33 and TSLP) | D. Thaci

08:37

Moncoinal antibodies targeting Th2 receptors and cytokines | Thomas Bieber

08:49

Topical JAK Inhibitors | Jonathan Silverberg

25:50

Atopic Comorbidities

13:32

Systemic JAK inhibitors | Eric Simpson

11:15

Monoclonal antibodies w/other targets (eg OX40,IL-22,IL-23)&biomarkers of disease response|E.Guttman

08:09

Novel Systemic Treatments in Pediatrics and Placebo Responses in Systemic Trials Prof Michael Cork

08:27

Optimizing Clinical Trial Design for AD drug development | Robert Bissonnette

07:15

IEC Welcome & Introduction @ EADV Emma Guttman

09:56

Thaci2020IEC Trim edited2

01:29:58

IEC Hand Eczema Virtual Symposium March 2021

26:47

Fireside Chat Panel Discussion

04:21

Welcome & Program Overview | Emma Guttman

10:35

Cytokines and chemokines as a possible biomarker in atopic dermatitis | Kenji Kabashima

10:21

Atopic Dermatitis 3.0: from clinical phenotypes to biomarker based endophenotypes | DirkJan Hijnen

15:02

Treatment response biomarkers and minimally invasive skin biomarkers | Emma Guttman

04:21

Welcome | Emma Guttman

10:31

Valeria Aoki | The Importance of Patient Education and Strategies for Delivery–A Global Perspective

09:46

Helen Alexander | The Role of the Microbiome & Skin Infections in Atopic Dermatitis

05:40

Sandipan Dhar | Skin Infections in AD

13:15

Carol Hlela | AD in Skin of Color

06:58

Amy Paller | Welcome & History of ISPD and IEC

01:32

Carsten Flohr | IEC Management of Pediatric AD - A Global Perspective Introduction

46:29

IEC at WCPD Discussion Panel & Closing Remarks All Faculty

31:43

IEC Panel Discussion | Human Models of Atopic Dermatitis IEC Panel All Faculty

09:56

Reiko Tanaka | Computational Models of Atopic Dermatitis

10:53

Kilian Eyerich | Human Models in Vivo

10:44

Jacob Thyssen | Environmental Exposures and Allergens

07:33

Sara Brown | Genetic Variation in Human Models

06:28

Nick Reynolds | Welcome and IEC Program Overview

10:40

Bethany E Perez White | Human Equivalent Models

09:06

Emma Guttman | Contact Dermatitis ACD and ICD in Facial Eczema

09:58

Jacob Thyssen | EPIDEMIOLOGY & BURDEN OF FACIAL AD

10:36

Robert Bissonnette | Treatment of AD involving the face

12:15

Jonathan Silverberg | Dupilumab associated Facial Skin Changes

07:58

David Cohen | Mechanisms of Sensitive Skin